AI Terminal
Diasorin
Declaration of Voting Results & Voting Rights Announcements • Sep 5, 2025
4129_rns_2025-09-05_a3f32652-9500-4bac-81b5-30318988fd5a.pdf
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 0957-45-2025 |
Data/Ora Inizio Diffusione 5 Settembre 2025 10:34:31 |
Euronext Milan | ||
|---|---|---|---|---|
| Societa' | : | DIASORIN | ||
| Identificativo Informazione Regolamentata |
: | 209682 | ||
| Utenza - referente | : | DIASORINN01 - Ulisse Spada - Valerio Vaccarone |
||
| Tipologia | : | 2.5 | ||
| Data/Ora Ricezione | : | 5 Settembre 2025 10:34:31 | ||
| Data/Ora Inizio Diffusione | : | 5 Settembre 2025 10:34:31 | ||
| Oggetto | : | Communication on total amount of voting rights | ||
| Testo del comunicato |
See attachment.
COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS PURSUANT TO ARTICLE 85-BIS, PARAGRAPH 4-BIS, OF CONSOB REGULATION NO. 11971/1999
Saluggia, September 5 th, 2025 – Diasorin S.p.A. ("Diasorin" or the "Company") hereby announces that some shareholders, holding equity interests lower than 3% of the overall voting rights – waived to the accrued increased voting rights, for overall no. 22,000 ordinary shares of the Company.
In accordance with Article 85-bis paragraph 4-bis, of Consob Regulation no. 11971/1999, the total amount of the voting rights is presented below, together with the number of shares making up the share capital:
| Status after assignment of increased voting rights |
Status before assignment of increased voting rights |
|||||
|---|---|---|---|---|---|---|
| Number of shares making up share capital |
No. of voting rights |
Euro | Number of shares making up share capital |
No. of voting rights |
Euro | |
| Total amount, of which: |
55,948,257 | 88,228,630 | 55,948,257 | 55,948,257 | 88,250,630 | 55,948,257 |
| Ordinary shares without increased voting rights ISIN IT0003492391 (regular dividend) Current coupon: no. 21 |
23,667,884 | 23,667,884 | - | 23,645,884 | 23,645,884 | - |
| Ordinary shares with increased voting rights ISIN IT0005188385 (regular dividend) Current coupon: no. 21 |
32,280,373 | 64,560,746 | - | 32,302,373 | 64,604,746 | - |
The Special List, updated in accordance with Article 9-quater of the Company By-Laws, is available on the Company website https://int.diasorin.com/, in the Section "Company/Governance/Ownership Structure/Loyalty shares".
Headquartered in Italy and listed at the Italian Stock Exchange in the FTSE MIB Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field and is active since 2021 in the Life Science business. For over 50 years, the Company has been developing, producing and marketing reagent kits used by diagnostic laboratories worldwide.
The Group operates in 5 continents through 31 companies, 4 branches, 10 manufacturing facilities and 9 research and development centers. The extensive diagnostic testing and Life Science offer, made available through continuous investments in research, positions DiaSorin as the player with the broadest range of specialty tests available within the diagnostic market, and identifies the Group as the "Diagnostic Specialist".
More info at www.diasorin.com
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
INVESTOR RELATIONS
Riccardo Fava Eugenia Ragazzo Corporate VP Communication, ESG & Investor Relations Corporate Investor Relations & ESG Analyst [email protected] [email protected]
| Fine Comunicato n.0957-45-2025 Numero di Pagine: 4 |
|---|
| ------------------------------------------------------- |